产品名称
MISSION® esiRNA, targeting human BOP1
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACACCCAGGTGCTGATTCACCAGCTGAGCCGTCGCCGCAGCCAGAGTCCGTTCCGCCGCAGCCACGGACAGGTGCAGCGAGTGGCCTTCCACCCTGCCCGGCCCTTCCTGTTGGTGGCGTCCCAGCGCAGCGTCCGCCTCTACCACCTGCTGCGCCAGGAGCTCACCAAGAAGCTGATGCCCAACTGCAAGTGGGTGTCCAGCCTGGCGGTGCACCCTGCAGGTGACAACGTCATCTGTGGGAGCTACGATAGCAAGCTGGTGTGGTTTGACCTGGATCTTTCCACCAAGCCATACAGGATGCTGAGACACCACAAGAAGGCTCTGCGGGCTGTGGCCTTCCACCCGCGGTACCCACTCTTTGCGTCAGGCTCGGACGACGGCAGTGTCATCGTCTGCCATGGCATGGTGTACAATGACCTTCTGCAGAACCCCTTGCTGGTGCCCGTCAAGGTGCTGAAGGGACACGTGCTGACCCGAGATCTGGGAGTGCTGGACGTCATCTT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... BOP1(23246), BOP1(23246)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Expression, Localization, and Function of the Nucleolar Protein BOP1 in Prostate Cancer Progression.
Jordan E Vellky et al.
The American journal of pathology, 191(1), 168-179 (2020-10-12)
Differentiating between indolent and aggressive prostate cancers (CaP) is important to decrease overtreatment and increase survival for men with the aggressive disease. Nucleolar prominence is a histologic hallmark of CaP; however, the expression, localization, and functional significance of specific nucleolar
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持